
ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily
Gene TherapyGenomicsSynthetic BiologyGene Base EditingCRSPR Gene Editing
Trader's Guide 2024Ships December 21st. Download our December Market Report and reserve your copy today.
Key Statistics
Statistics
⚖️Weighting | 🧢Market Cap |
---|---|
2.9% | $2.76b |
🏋🏿♂️Weight Rank In ARKK | 🌏Country |
13 | 🇺🇸United States |
🏋️♀️Weight Rank Across All Funds | 💳ARK Estimated Cost Average |
15 | $62.04 |
🎫ARK Ownership Percent | |
8.78% |
Other ETFs That Hold NTLA
Research Notes and Commentary for NTLA
No Research Notes Found for NTLA